Study of adrenal tumors—causes and possible treatments
Part of Cancer, Hormones & metabolism clinical trials.
This study looks at adrenal tumors found on imaging (scans) to better understand what causes them and how they might be treated. If you have an adrenal tumor on a scan, this trial may be looking to enroll you for that purpose.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have an adrenal tumor seen on a scan (imaging).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is a registry that collects information from people diagnosed with adrenocortical carcinoma (a rare cancer of the adrenal gland). It can help doctors understand the disease and improve future care by tracking outcomes and treatments.
This study follows adults with a new adrenal diagnosis to learn how adrenal diseases behave over time. It may help doctors better understand these conditions and improve future care.
This study looks at how Cushing’s syndrome affects people before treatment and what changes after treatment. It may help researchers understand what to expect and improve care for adults with newly diagnosed Cushing’s syndrome.
This trial tests whether combining camrelizumab (an immune treatment) with apatinib (a targeted drug) can shrink recurrent or metastatic adrenal cancer after standard treatment didn’t work. It may help some people control tumor growth when other treatments have already been tried.
This study looks at genetic (DNA) changes in people with pheochromocytoma or paraganglioma and related conditions. It may help clarify why these conditions happen and how they run in families.
This study looks at CT scans of people with adrenal tumors to understand how the tumor might affect your metabolism. It may help doctors learn more about the condition and improve care.
Hear when a new Adrenocortical Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.